Keyphrases
Synergism
100%
Drug Resistance
100%
Breast Cancer Progression
100%
HER2 Signaling
100%
Breast Cancer Drugs
100%
PHF8
100%
Human Epidermal Growth Factor Receptor 2 (HER2)
80%
Breast Cancer
30%
Interleukin-6
20%
HER2-targeted Therapy
20%
HER2-positive Breast Cancer
20%
RNA Sequencing (RNA-seq)
10%
Cell-based
10%
Mouse Model
10%
Acquired Resistance
10%
T Cells
10%
Quantitative PCR
10%
Infiltration
10%
Poor Prognosis
10%
Mechanistic Insight
10%
Epithelial-to-mesenchymal Transition
10%
Trastuzumab
10%
Synergistic Interaction
10%
Feed-forward Loop
10%
Epigenetic Factors
10%
Cytokine Secretion
10%
Newly Established
10%
Histone Demethylase
10%
Coactivator
10%
Oncogenic Function
10%
Overcoming Resistance
10%
Young Investigators
10%
Research Awards
10%
Tumourigenesis
10%
Breast Cancer Research
10%
Six-axis
10%
Regulatory Axis
10%
Pharmacology, Toxicology and Pharmaceutical Science
Synergism
100%
Breast Cancer
100%
Drug Resistance
100%
Cytokine
40%
Interleukin 6
40%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
40%
Mouse Mammary Tumor Virus
40%
Mouse Model
20%
Carcinogenesis
20%
Trastuzumab
20%
Enzyme-Linked Immunosorbent Assay
20%
RNA-Sequencing
20%
Histone Demethylase
20%
Medicine and Dentistry
Drug Resistance
100%
Breast Cancer
100%
Interleukin 6
40%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
40%
Mouse Mammary Tumor Virus
40%
Cytokine
20%
RNA Sequence
20%
In Vitro
20%
Real-Time Polymerase Chain Reaction
20%
Carcinogenesis
20%
T Cell
20%
Enzyme Linked Immunosorbent Assay
20%
Cell Line
20%
Cancer Research
20%
Mesenchymal-Epithelial Transition
20%
Cytokine Release
20%
Trastuzumab
20%
Histone Demethylase
20%
Biochemistry, Genetics and Molecular Biology
Drug Resistance
100%
PHF8
100%
Interleukin 6
22%
Mouse Mammary Tumor Virus
22%
Cytokine
11%
Epigenetics
11%
Real-Time Polymerase Chain Reaction
11%
RNA Sequence
11%
Mouse Model
11%
T Cell
11%
Carcinogenesis
11%
Mesenchymal-Epithelial Transition
11%
Transcription
11%
Demethylase
11%
Trastuzumab
11%
Cytokine Release
11%
Histone
11%